v3.26.1
Corporate and Group information (Tables)
6 Months Ended
Jun. 30, 2026
Disclosure Of Corporate And Group Information [Abstract]  
Summary of Subsidiaries

The unaudited condensed consolidated interim financial statements of the Group include:

 

 

 

 

 

Country of

 

% of equity interest as
June 30,

Name

 

Legal seat

 

incorporation

 

2026

 

2025

Pharvaris Holdings B.V.

 

Leiden

 

The Netherlands

 

100%

 

100%

Pharvaris Netherlands B.V.

 

Leiden

 

The Netherlands

 

100%

 

100%

Pharvaris GmbH

 

Zug

 

Switzerland

 

100%

 

100%

Pharvaris, Inc.

 

Delaware

 

United States of America

 

100%

 

100%

Pharvaris Pharmaceuticals, Inc.*

 

Delaware

 

United States of America

 

100%

 

100%

*Pharvaris Pharmaceuticals, Inc was incorporated in June 2025